Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

NCT ID: NCT04527861

Last Updated: 2022-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

710 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-08

Study Completion Date

2029-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to improve cosmetic effect and reduce postoperative pain, single-incision laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the next major advance in the progress of minimally invasive surgical approaches to colorectal disease that is more feasible in generalized use. In most previous studies, SILS for colorectal cancer was feasible and short-term safe compared to conventional laparoscopic surgery (CLS) . However, there is still controversy over its potential better cosmetic effect and less postoperative pain. Moreover, the long-term oncologic outcomes are still inconclusive as only a few studies showed long-term survival data. Up to now, most studies were limited to their retrospective nature and small samples. So more studies, especially large-scale, randomized controlled trials are needed to establish the best indications for SILS for colorectal cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Colon Cancer Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-incision Laparoscopic Surgery

Patients with colorectal cancer undergo single-incision laparoscopic surgery.

Group Type EXPERIMENTAL

Single-incision Laparoscopic Surgery

Intervention Type PROCEDURE

In this group,the surgery is performed through a single incision. The surgeon will adjust surgical position to expose the operative field with the help of gravity. Besides,hand over hand cross and parallel techniques are needed to achieve the SILS. All the other operative procedures are the same as conventional laparoscopic surgery.

Conventional Laparoscopic Surgery

Patients with colorectal cancer undergo conventional laparoscopic surgery(3\~5 ports).

Group Type ACTIVE_COMPARATOR

Conventional Laparoscopic Surgery

Intervention Type PROCEDURE

In this group,the surgery is performed through 3-5 ports according to the surgeons habits and specific conditions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Single-incision Laparoscopic Surgery

In this group,the surgery is performed through a single incision. The surgeon will adjust surgical position to expose the operative field with the help of gravity. Besides,hand over hand cross and parallel techniques are needed to achieve the SILS. All the other operative procedures are the same as conventional laparoscopic surgery.

Intervention Type PROCEDURE

Conventional Laparoscopic Surgery

In this group,the surgery is performed through 3-5 ports according to the surgeons habits and specific conditions.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SILS CLS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years \< age ≤85 years
* Tumor located in colon and high rectum ( the lower border of the tumor is above the peritoneal reflection)
* Pathological or highly suspected colorectal carcinoma
* Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual
* Tumor size of 5 cm or less
* ECOG score is 0-1
* ASA score is Ⅰ-Ⅲ
* Informed consent

Exclusion Criteria

* Body mass index (BMI) \>35 kg/m2
* The lower border of the tumor is located distal to the peritoneal reflection
* Familial adenomatous polyposis (FAP)
* Inflammatory bowel disease (IBD)
* Multiple malignant colorectal tumors
* Pregnant woman or lactating woman
* Severe mental disease
* Previous gastrointestinal surgery (except appendectomy )
* Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer
* Requirement of simultaneous surgery for other disease
* Simultaneous or metachronous multiple cancers with disease-free survival ≤ 5 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dongfang Hospital Affiliated to Tongji University

OTHER

Sponsor Role collaborator

Fudan University

OTHER

Sponsor Role collaborator

Changhai Hospital

OTHER

Sponsor Role collaborator

Shengjing Hospital

OTHER

Sponsor Role collaborator

RenJi Hospital

OTHER

Sponsor Role collaborator

Liaoning Cancer Hospital & Institute

OTHER

Sponsor Role collaborator

Zhejiang Provincial People's Hospital

OTHER

Sponsor Role collaborator

Shandong Provincial Hospital

OTHER_GOV

Sponsor Role collaborator

The General Hospital of Western Theater Command

OTHER

Sponsor Role collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role collaborator

Ruijin Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhao Ren

Chief Physicion

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ren Zhao, MD, PHD

Role: PRINCIPAL_INVESTIGATOR

Ruijin Hospitlal , Shanghai Jiaotong University School of Medicine

Chun Song, MD

Role: STUDY_DIRECTOR

Dongfang Hospital Affiliated to Tongji University

Ye Xu, MD

Role: STUDY_DIRECTOR

Shanghai Cancer Center

Liqiang Hao, MD

Role: STUDY_DIRECTOR

Changhai Hospital

Hong Zhang, MD

Role: STUDY_DIRECTOR

Shengjing Hospital

Hong Zhou, MD

Role: STUDY_DIRECTOR

RenJi Hospital

Qingtong Zhang, MD

Role: STUDY_DIRECTOR

Liaoning Cancer Hospital & Institute

Shiliang Tu, MD

Role: STUDY_DIRECTOR

Zhejiang Provincial People's Hospital

Xiaoqiao Zhang, MD

Role: STUDY_DIRECTOR

Shandong Provincial Hospital

Lin Zhang, MD

Role: STUDY_DIRECTOR

The General Hospital of Western Theater Command

Feng Gao, MD

Role: STUDY_DIRECTOR

The 940th Hospital of Joint Logistic Support Force of Chinese of PLA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The 940th Hospital of Joint Logistic Support Force of Chinese of PLA

Lanzhou, Gansu, China

Site Status RECRUITING

Shengjing Hospital

Shenyang, Liaoning, China

Site Status RECRUITING

Liaoning Tumor Hospital & Institute

Shenyang, Liaoning, China

Site Status RECRUITING

Shandong Provincial Hospital

Jinan, Shandong, China

Site Status RECRUITING

The General Hospital of Western Theater Command

Chengdu, Sichuan, China

Site Status RECRUITING

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China

Site Status RECRUITING

Shanghai Cancer Center

Shanghai, , China

Site Status RECRUITING

Dongfang Hospital Affiliated to Tongji University

Shanghai, , China

Site Status RECRUITING

RenJi Hospital

Shanghai, , China

Site Status RECRUITING

Changhai Hospital

Shanghai, , China

Site Status RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ren Zhao, MD, PHD

Role: CONTACT

+8618917762018

Kun Liu, MD

Role: CONTACT

+8618121263082

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Feng Gao, MD

Role: primary

Hong Zhang, MD

Role: primary

Qingtong Zhang, MD

Role: primary

Xiaoqiao Zhang, MD

Role: primary

Lin Zhang, MD

Role: primary

Shiliang Tu, MD

Role: primary

Ye Xu, MD

Role: primary

Chun Song, MD

Role: primary

Hong Zhou, MD

Role: primary

Liqiang Hao, MD

Role: primary

Kun Liu, MD

Role: primary

+8618121263082

References

Explore related publications, articles, or registry entries linked to this study.

Maggiori L, Tuech JJ, Cotte E, Lelong B, Denost Q, Karoui M, Vicaut E, Panis Y. Single-incision Laparoscopy Versus Multiport Laparoscopy for Colonic Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial. Ann Surg. 2018 Nov;268(5):740-746. doi: 10.1097/SLA.0000000000002836.

Reference Type BACKGROUND
PMID: 30303873 (View on PubMed)

Lee YS, Kim JH, Kim HJ, Lee SC, Kang BM, Kim CW, Lim SW, Lee SH, Kim JG. Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial. Ann Surg. 2021 Feb 1;273(2):217-223. doi: 10.1097/SLA.0000000000003882.

Reference Type BACKGROUND
PMID: 32209897 (View on PubMed)

Song Z, Liu K, Zhang T, Wang B, Shi Y, Jiang Y, Wang C, Chen X, Ji X, Zhao R. Oncologic outcomes of single-incision laparoscopic surgery versus conventional laparoscopic surgery for colorectal cancer (CSILS): study protocol for a multicentre, prospective, open-label, noninferiority, randomized controlled trial. BMC Cancer. 2022 Jul 7;22(1):743. doi: 10.1186/s12885-022-09821-9.

Reference Type DERIVED
PMID: 35799145 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSILS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Outcome of Resection for Colorectal Cancer
NCT03837782 ENROLLING_BY_INVITATION NA